Andras Incze

András Incze is the CEO and Founder of Akceso Advisors AG, a company he established in early 2011.1 He has over 20 years of experience in the pharmaceutical industry, holding various roles at country, regional, and global levels.1

András has a strong background in pharmaceutical pricing and market access. He previously worked as a Market Pricing Director and Head of Global Pricing Analysis at Novartis, where he managed pricing and reimbursement for 100 markets across the full pharmaceutical portfolio.1 During his tenure, he successfully launched 15 general medicine, specialist, and orphan compounds.1

His educational background includes:

• An MBA from IMD Business School
• An MSc and Doctorate (PhD) from BME Budapest
• Executive programs at Harvard, Stanford, IMD, and INSEAD1

András is also an author and educator. He has co-authored two books on health economics and pricing, developed four case studies with Harvard, and is an invited speaker at conferences and the IMD business school.1 He currently resides in Basel, Switzerland.1

At Akceso Advisors, András leads engagements with various clients, leveraging his extensive experience in the pharmaceutical industry.1 His expertise spans original, generic, and biosimilar products, including lifecycle transitions.1 He has worked with payers and authorities to shape national healthcare landscapes in countries such as Argentina, Egypt, Poland, and Saudi Arabia.1